Results 121 to 130 of about 827 (146)

Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ENGOT-OV26/GOG-3012 trial. [PDF]

Ann Oncol
Monk BJ, Barretina-Ginesta MP, Pothuri B, Vergote I, Graybill W, Mirza MR, McCormick CC, Lorusso D, Moore RG, Freyer G, O'Cearbhaill RE, Heitz F, O'Malley DM, Redondo A, Shahin MS, Vulsteke C, Bradley WH, Haslund CA, Chase DM, Pisano C, Holman LL, Pérez MJR, DiSilvestro P, Gaba L, Herzog TJ, Bruchim I, Compton N, Shtessel L, Malinowska IA, González-Martín A.   +29 more
europepmc   +1 more source

[Retroperitoneal lymphadenopathy trans-vertebral image-guided biopsy: a case report] [PDF]

Rev Fac Cien Med Univ Nac Cordoba, 2022
Rendon FO, Del Valle JB, Valeo Chulvi MP, Dalurzo ML, Santino JP, Borensztein MA.   +5 more
europepmc   +1 more source

Preoperative neutrophil/lymphocyte ratio as prognostic factor in epithelial ovarian cancer [PDF]

Rev Colomb Obstet Ginecol
Vázquez Rojo J, Vázquez Reguera J, Sánchez del Río A.   +2 more
europepmc   +1 more source

[Obstetric-gynecological and social factors for the development of cervical intraepithelial neoplasia]. [PDF]

Rev Med Inst Mex Seguro Soc
Villanueva-Duque JA, Castro-Valdés IC, García-Cervantes N.   +2 more
europepmc   +1 more source

Pan-Asia adapted ESMO Clinical Practice Guideline for the management of patients with newly diagnosed and relapsed epithelial ovarian cancer. [PDF]

ESMO Open
Nag S, Ray Coquard I, Gupta S, Pathak A, Li N, Mulya Sari R, Harano K, Kim GM, Ang SF, Que FV, Chay WY, Lai HC, Ativitavas T, Tangjitgamol S, Lai CH, Heong VYM, Contreras Tolentino J, Ngu MR, Yun J, Yunokawa M, Hanafi WLH, Li J, Smyth E, Yoshino T, Mehta J, Pentheroudakis G, Maheshwari A, Cervantes A, Basade M, Oaknin A.   +29 more
europepmc   +1 more source

Citología y prueba VPH en canal anal en mujeres con neoplasia cervical y cáncer. Medellín, Colombia

Objetivo: Determinar la relación de la citología convencional y la prueba del Virus del Papiloma Humano de alto riesgo (VPH-AR) en canal anal, en mujeres con antecedentes de neoplasia intraepitelial cervical de alto grado (NIC-AG) y cáncer de cuello ...
Martinez Arrieta, Leyci Judith
core  

ENGOT-EN20/GOG-3083/XPORT-EC-042 - A phase III, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy after systemic therapy for patients with p53 wild-type, advanced, or recurrent endometrial carcinoma: rationale, methods, and trial design. [PDF]

Int J Gynecol Cancer
Vergote I, Perez Fidalgo A, Valabrega G, Monk BJ, Herzog T, Cibula D, Colombo N, Pothuri B, Sehouli J, Korach J, Barlin J, Papadimitriou CA, van Gorp T, Richardson D, McCarthy M, Antill Y, Mirza MR, Li K, Kalyanapu P, Slomovitz B, Coleman RL.   +20 more
europepmc   +1 more source

Atezolizumab, bevacizumab, and platinum chemotherapy in cervical cancer: results of Japanese population from BEATcc. [PDF]

J Gynecol Oncol
Takekuma M, Nishio S, Yamaguchi S, Yunokawa M, Nishio H, Nishino K, Kurosaki A, Minobe S, Villacampa G, Oaknin A, Okamoto A.   +10 more
europepmc   +1 more source

Effect of a new nursing organization management mode constructed by appreciative inquiry on gynecological tumor patients in the perioperative period. [PDF]

Rev Esc Enferm USP
Fang C, Yang J.
europepmc   +1 more source

Abemaciclib for treating patients with HR+/HER2- metastatic breast cancer: a real-world study in France, Italy and Spain. [PDF]

Future Oncol
Blancas I, Grosjean J, Pedersini R, Buzzoni C, Sleilaty G, Molero A, Tamma A, Chouaki N, Atienza M, Emde A, Siddi S, Sanchez Bayona R, Del Mastro L, Fakhouri W.   +13 more
europepmc   +1 more source